Home/Pipeline
Program
PreclinicalPhase 1Phase 2Phase 3FiledApproved
Next milestoneCLV-147Ovarian cancerOncology · ADC
Dose escalation complete
CLV-233LupusImmunology · Cell therapy
First patient dosed
CLV-427Lp(a) elevationCardiometabolic · RNA
Single ascending dose complete
CLV-515Fabry diseaseRare Disease · RNA
First cohort dosed
Pipeline as of September 30, 2026. Programs and data are fictional.